Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosus.

Authors	François Chasset, Léa Jaume, Alexis Mathian, Noémie Abisror, Amélie Dutheil, Annick Barbaud, Diane Kottler, Céline Girard, Sandrine Jousse-Joulin, Marie Tauber, Cristina Bulai Livideanu, Véronique Avettand-Fenoel, Raphael Lhote, Micheline Pha, Zahir Amoura, EMSED (Etude des maladies systémiques en dermatologie) study group
Journal	Journal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 89 Issue 1 Pg. 171-173 (07 2023) ISSN: 1097-6787 [Electronic] United States
PMID	36878316 (Publication Type: Journal Article)
Chemical References	anifrolumab Antibodies, Monoclonal, Humanized Immunosuppressive Agents
Topics	Humans Antibodies, Monoclonal, Humanized (therapeutic use) Immunosuppressive Agents Lupus Erythematosus, Cutaneous (drug therapy) Lupus Erythematosus, Systemic Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!